(Q43001576)

12 November 2017

Steatosis in chronic hepatitis C: relationship to the virus and host risk factors (English)

1 reference

12 November 2017

1 reference

1 reference

Carla A L Matos

1

1 reference

12 November 2017

Renata M Perez

2

1 reference

12 November 2017

Mauricio S Pacheco

3

1 reference

12 November 2017

Claudio G Figueiredo-Mendes

4

1 reference

12 November 2017

Edmundo Lopes-Neto

5

1 reference

12 November 2017

Evandro B Oliveira

6

1 reference

12 November 2017

Valeria P Lanzoni

7

1 reference

12 November 2017

Antonio E B Silva

8

1 reference

12 November 2017

Maria L G Ferraz

9

1 reference

12 November 2017

language of work or name

1 reference

1 August 2006

1 reference

Journal of Gastroenterology and Hepatology

12 November 2017

1 reference

12 November 2017

21

1 reference

12 November 2017

8

1 reference

12 November 2017

1236-1239

1 reference

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

12 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04308.X

Guidelines for healthy weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04308.X

Nonalcoholic Steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04308.X

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04308.X

Importance of age in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04308.X

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04308.X

Hepatic steatosis in hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04308.X

Steatosis affects chronic hepatitis C progression in a genotype specific way

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04308.X

Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04308.X

The nomenclature of chronic active hepatitis: an obituary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04308.X

Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04308.X

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04308.X

Nonalcoholic steatohepatitis: An expanded clinical entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04308.X

Host- and disease-specific factors affecting steatosis in chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04308.X

10.1111/J.1440-1746.2006.04308.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference